Skip to content

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.

The question sounds more like sociology than biology: What would happen if you could take a cell gone bad -- a cancer cell -- bring …

As I reported in this week's issue of Inside Stanford Medicine, Scott Metzler, PhD, is a researcher who not only studies the early development of …